Health care providers can take steps to protect patients targeted by ICE, ensuring that patients retain their privacy and access to care.

US inspectors have uncovered breakdowns in drugmaking at an Indian factory owned by Sun Pharma that produces generic medications for American consumers.

Hospital officials are warning that changes in President Donald Trump’s budget and tax bill put them on an unsustainable track that could lead to closures or loss of services in rural communities.

Systematic mediastinal lymph node dissection (LND) is “unnecessary” for patients with ground glass opacity (GGO)-dominant invasive lung adenocarcinoma and low risk of nodal involvement, according to ...

The study results “highlight how even well-intentioned efforts to save patients’ time may face barriers,” the researchers wrote.

Prognostic Nutritional Index and systemic oxidative stress scores are associated with prognosis in patients with low-risk MDS, data suggest.

The FDA has decided not to approve vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.

Resources available to clinical research physicians and the expectations placed upon these individuals vary across cancer cancers, data suggest.

Researchers recommend that details on prescription medications received in the year before diagnosis and treatment initiation be included in clinical trials as essential baseline information.

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.

The study results “indicate that the public has certain reservations about the integration of AI in health care,” the researchers wrote.